BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32473361)

  • 21. Evaluation of dual nasal delivery of infectious hematopoietic necrosis virus and enteric red mouth vaccines in rainbow trout (Oncorhynchus mykiss).
    LaPatra S; Kao S; Erhardt EB; Salinas I
    Vaccine; 2015 Feb; 33(6):771-6. PubMed ID: 25562788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic and cross-protection studies of biotype 1 and biotype 2 isolates of Yersinia ruckeri in rainbow trout, Oncorhynchus mykiss (Walbaum).
    Tinsley JW; Lyndon AR; Austin B
    J Appl Microbiol; 2011 Jul; 111(1):8-16. PubMed ID: 21447021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of in-feed specific IgM towards Yersinia ruckeri in rainbow trout.
    Chettri JK; Al-Jubury A; Hansen MB; Lihme A; Dalsgaard I; Buchmann K; Heegaard PMH
    Fish Shellfish Immunol; 2019 Oct; 93():934-939. PubMed ID: 31404633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Lactobacillus rhamnosus ATCC 7469 on Different Parameters Related to Health Status of Rainbow Trout (Oncorhynchus mykiss) and the Protection Against Yersinia ruckeri.
    Hooshyar Y; Abedian Kenari A; Paknejad H; Gandomi H
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1370-1384. PubMed ID: 32246325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss).
    Ma J; Casadei E; Bruce TJ; Sepahi A; Cain KD; Salinas I
    Vaccine; 2022 Jan; 40(2):229-238. PubMed ID: 34893343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral and anal vaccination confers full protection against enteric redmouth disease (ERM) in rainbow trout.
    Villumsen KR; Neumann L; Ohtani M; Strøm HK; Raida MK
    PLoS One; 2014; 9(4):e93845. PubMed ID: 24705460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling in naïve and vaccinated rainbow trout after Yersinia ruckeri infection: insights into the mechanisms of protection seen in vaccinated fish.
    Harun NO; Wang T; Secombes CJ
    Vaccine; 2011 Jun; 29(26):4388-99. PubMed ID: 21504776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immersion vaccines against Yersinia ruckeri infection in rainbow trout: Comparative effects of strain differences.
    Yang H; Zhujin D; Marana MH; Dalsgaard I; Rzgar J; Heidi M; Asma KM; Per KW; Kurt B
    J Fish Dis; 2021 Dec; 44(12):1937-1950. PubMed ID: 34392540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible effect of hala extract (Pandanus tectorius) on immune status, anti-tumour and resistance to Yersinia ruckeri infection in rainbow trout (Oncorhynchus mykiss).
    Awad E; Austin D; Lyndon A; Awaad A
    Fish Shellfish Immunol; 2019 Apr; 87():620-626. PubMed ID: 30753919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An oral DNA vaccine against infectious haematopoietic necrosis virus (IHNV) encapsulated in alginate microspheres induces dose-dependent immune responses and significant protection in rainbow trout (Oncorrhynchus mykiss).
    Ballesteros NA; Alonso M; Saint-Jean SR; Perez-Prieto SI
    Fish Shellfish Immunol; 2015 Aug; 45(2):877-88. PubMed ID: 26054788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insight from molecular, pathological, and immunohistochemical studies on cellular and humoral mechanisms responsible for vaccine-induced protection of rainbow trout against Yersinia ruckeri.
    Deshmukh S; Kania PW; Chettri JK; Skov J; Bojesen AM; Dalsgaard I; Buchmann K
    Clin Vaccine Immunol; 2013 Oct; 20(10):1623-41. PubMed ID: 23966555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial peptide CAP18 and its effect on Yersinia ruckeri infections in rainbow trout Oncorhynchus mykiss (Walbaum): comparing administration by injection and oral routes.
    Chettri JK; Mehrdana F; Hansen EB; Ebbensgaard A; Overgaard MT; Lauritsen AH; Dalsgaard I; Buchmann K
    J Fish Dis; 2017 Jan; 40(1):97-104. PubMed ID: 27334068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a Eudragit L30D-55 encapsulated oral vaccine containing inactivated bacteria (Lactococcus garvieae/Streptococcus iniae) in rainbow trout (Oncorhynchus mykiss).
    Halimi M; Alishahi M; Abbaspour MR; Ghorbanpoor M; Tabandeh MR
    Fish Shellfish Immunol; 2018 Oct; 81():430-437. PubMed ID: 30056210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-adjuvanted flagellin elicits a non-specific protective immune response in rainbow trout (Oncorhynchus mykiss, Walbaum) towards bacterial infections.
    Scott CJ; Austin B; Austin DA; Morris PC
    Vaccine; 2013 Jul; 31(32):3262-7. PubMed ID: 23707165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trans-cinnamic acid application for rainbow trout (Oncorhynchus mykiss): I. Effects on haematological, serum biochemical, non-specific immune and head kidney gene expression responses.
    Yılmaz S; Ergün S
    Fish Shellfish Immunol; 2018 Jul; 78():140-157. PubMed ID: 29684602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant efficacy of G2 (buffalo spleen extraction) against Yersinia septicemia in rainbow trout (Onchorhynchus mykiss).
    Shafie S; Soltani E; Soltani M; Hazrati SM
    Fish Shellfish Immunol; 2018 Nov; 82():115-120. PubMed ID: 30092257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hen egg yolk immunoglobulin in passive protection of rainbow trout against Yersinia ruckeri.
    Lee SB; Mine Y; Stevenson RM
    J Agric Food Chem; 2000 Jan; 48(1):110-5. PubMed ID: 10637061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune gene expression and genome-wide association analysis in rainbow trout with different resistance to Yersinia ruckeri infection.
    Zuo S; Karami AM; Ødegård J; Mathiessen H; Marana MH; Jaafar RM; von Gersdorff Jørgensen L; Abdu M; Kania PW; Dalsgaard I; Nielsen T; Buchmann K
    Fish Shellfish Immunol; 2020 Nov; 106():441-450. PubMed ID: 32791094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential use of a Yersinia ruckeri O1 auxotrophic aroA mutant as a live attenuated vaccine.
    Temprano A; Riaño J; Yugueros J; González P; de Castro L; Villena A; Luengo JM; Naharro G
    J Fish Dis; 2005 Jul; 28(7):419-27. PubMed ID: 16083447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of HMB (beta-hydroxy-beta-methylbutyrate) on antibody secreting cells (ASC) after in vitro and in vivo immunization with the anti-Yersinia ruckeri vaccine of rainbow trout (Oncorhynchus mykiss).
    Siwicki AK; Morand M; Fuller JC; Nissen S; Kazun K; Glombski E
    Vet Res; 2001; 32(5):491-8. PubMed ID: 11592618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.